DexCom EBITDA 2006-2018 | DXCM
DexCom annual and quarterly EBITDA history from 2006 to 2018. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- DexCom EBITDA for the quarter ending December 31, 2018 was $-0.156B, a 1062.96% decline year-over-year.
- DexCom EBITDA for the twelve months ending December 31, 2018 was $-0.157B, a 495.45% increase year-over-year.
- DexCom 2018 annual EBITDA was $-0.157B, a 495.45% increase from 2017.
- DexCom 2017 annual EBITDA was $-0.026B, a 46.01% decline from 2016.
- DexCom 2016 annual EBITDA was $-0.049B, a 5.62% increase from 2015.
| DexCom Annual EBITDA (Millions of US $) |
|
|---|---|
| 2018 | $-157 |
| 2017 | $-26 |
| 2016 | $-49 |
| 2015 | $-46 |
| 2014 | $-13 |
| 2013 | $-21 |
| 2012 | $-48 |
| 2011 | $-40 |
| 2010 | $-42 |
| 2009 | $-42 |
| 2008 | $-50 |
| 2007 | $-44 |
| 2006 | $-47 |
| 2005 | $-31 |
| DexCom Quarterly EBITDA (Millions of US $) |
|
|---|---|
| Q4 2018 | $-156 |
| Q3 2018 | $22 |
| Q2 2018 | $2 |
| Q1 2018 | $-25 |
| Q4 2017 | $16 |
| Q3 2017 | $4 |
| Q2 2017 | $-10 |
| Q1 2017 | $-37 |
| Q4 2016 | $-3 |
| Q3 2016 | $-14 |
| Q2 2016 | $-16 |
| Q1 2016 | $-16 |
| Q4 2015 | $4 |
| Q3 2015 | $-40 |
| Q2 2015 | $-1 |
| Q1 2015 | $-10 |
| Q4 2014 | $4 |
| Q3 2014 | $-3 |
| Q2 2014 | $-4 |
| Q1 2014 | $-10 |
| Q4 2013 | $-0 |
| Q3 2013 | $-4 |
| Q2 2013 | $-8 |
| Q1 2013 | $-9 |
| Q4 2012 | $-6 |
| Q3 2012 | $-15 |
| Q2 2012 | $-13 |
| Q1 2012 | $-14 |
| Q4 2011 | $-11 |
| Q3 2011 | $-12 |
| Q2 2011 | $-6 |
| Q1 2011 | $-11 |
| Q4 2010 | $-9 |
| Q3 2010 | $-12 |
| Q2 2010 | $-10 |
| Q1 2010 | $-10 |
| Q4 2009 | $-9 |
| Q3 2009 | $-11 |
| Q2 2009 | $-12 |
| Q1 2009 | $-10 |
| Q4 2008 | $-12 |
| Q3 2008 | $-13 |
| Q2 2008 | $-13 |
| Q1 2008 | $-12 |
| Q4 2007 | $-12 |
| Q3 2007 | $-11 |
| Q2 2007 | $-11 |
| Q1 2007 | $-11 |
| Q4 2006 | $-11 |
| Q3 2006 | $-14 |
| Q2 2006 | $-11 |
| Q1 2006 | $-11 |
| Q4 2005 | $-12 |
| Q3 2005 | $-7 |
| Q2 2005 | $-7 |
| Q1 2005 | $-6 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $11.167B | $1.032B |
| Dexcom Inc. is developing continuous glucose monitoring systems for people with diabetes. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $107.252B | 24.17 |
| Intuitive Surgical (ISRG) | United States | $64.916B | 60.64 |
| Edwards Lifesciences (EW) | United States | $39.351B | 40.30 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $24.130B | 16.52 |
| IDEXX Laboratories (IDXX) | United States | $18.856B | 51.34 |
| ABIOMED (ABMD) | United States | $14.122B | 93.22 |
| Teleflex (TFX) | United States | $13.787B | 30.23 |
| Hologic (HOLX) | United States | $13.636B | 20.62 |
| Varian Medical Systems (VAR) | United States | $12.592B | 31.45 |
| STERIS (STE) | United Kingdom | $10.357B | 26.62 |
| Masimo (MASI) | United States | $7.154B | 44.55 |
| Penumbra (PEN) | United States | $5.449B | 308.33 |
| Globus Medical (GMED) | United States | $4.745B | 28.80 |
| Integra LifeSciences Holdings (IART) | United States | $4.697B | 22.77 |
| LivaNova (LIVN) | United Kingdom | $4.646B | 28.64 |
| Tandem Diabetes Care (TNDM) | United States | $3.991B | 0.00 |
| Wright Medical Group (WMGI) | Netherlands | $3.987B | 0.00 |
| Glaukos (GKOS) | United States | $2.895B | 0.00 |
| Cantel Medical (CMD) | United States | $2.758B | 27.43 |
| Integer Holdings (ITGR) | United States | $2.680B | 21.86 |
| Inogen (INGN) | United States | $2.002B | 39.90 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.941B | 21.08 |
| Nevro (NVRO) | United States | $1.902B | 0.00 |
| OPKO Health (OPK) | United States | $1.551B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $1.144B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $1.102B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $1.068B | 29.02 |
| Veracyte (VCYT) | United States | $1.059B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $1.053B | 199.93 |
| Luminex (LMNX) | United States | $1.050B | 47.98 |
| CryoLife (CRY) | United States | $1.046B | 112.76 |
| Intersect ENT (XENT) | United States | $0.961B | 0.00 |
| Fluidigm (FLDM) | United States | $0.960B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.870B | 35.59 |
| Natus Medical (BABY) | United States | $0.865B | 18.03 |
| AxoGen (AXGN) | United States | $0.834B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.813B | 26.36 |
| ViewRay (VRAY) | United States | $0.779B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.661B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.564B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.462B | 48.72 |
| TransEnterix (TRXC) | United States | $0.456B | 0.00 |
| Si-Bone (SIBN) | United States | $0.456B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.408B | 0.00 |
| Accuray (ARAY) | United States | $0.408B | 0.00 |
| Corindus Vascular Robotics (CVRS) | United States | $0.388B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.377B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.352B | 51.36 |
| IRadimed (IRMD) | United States | $0.309B | 65.42 |
| SeaSpine Holdings (SPNE) | United States | $0.282B | 0.00 |
| Sientra (SIEN) | United States | $0.277B | 0.00 |
| Neuronetics (STIM) | United States | $0.262B | 0.00 |
| Nuvectra (NVTR) | United States | $0.220B | 0.00 |
| CRH Medical (CRHM) | Canada | $0.188B | 43.67 |
| ConforMIS (CFMS) | United States | $0.181B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.160B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.152B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.122B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.121B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.119B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.115B | 0.00 |
| SOLITON INC (SOLY) | $0.105B | 0.00 | |
| Second Sight Medical Products (EYES) | United States | $0.103B | 0.00 |
| Vermillion (VRML) | United States | $0.093B | 0.00 |
| EDAP TMS (EDAP) | France | $0.083B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.076B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.075B | 0.00 |
| Titan Medical (TMDI) | Canada | $0.065B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.050B | 0.00 |
| Electromed (ELMD) | United States | $0.045B | 23.13 |
| Viveve Medical (VIVE) | United States | $0.044B | 0.00 |
| Xtant Medical Holdings (XTNT) | United States | $0.037B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.036B | 0.00 |
| Avinger (AVGR) | United States | $0.036B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.034B | 0.00 |
| Navidea Biopharmaceuticals (NAVB) | United States | $0.029B | 0.00 |
| PAVmed (PAVM) | United States | $0.028B | 0.00 |
| Restoration Robotics (HAIR) | United States | $0.027B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.026B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.025B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.022B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.020B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.020B | 65.67 |
| Dynatronics (DYNT) | United States | $0.016B | 0.00 |
| American Shared Hospital Services (AMS) | United States | $0.016B | 12.44 |
| ReWalk Robotics (RWLK) | Israel | $0.015B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.015B | 0.00 |
| Presbia (LENS) | Ireland | $0.013B | 0.00 |
| Neovasc (NVCN) | Canada | $0.012B | 0.00 |
| Micron Solutions (MICR) | United States | $0.008B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.007B | 0.00 |
| Cesca Therapeutics (KOOL) | United States | $0.006B | 0.00 |
| InspireMD (NSPR) | Israel | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.002B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.000B | 0.00 |
